Yahoo Finance

Organicell Regenerative Medicine, Inc. Closes $5.5 Million Funding Round

MIAMI, FL / ACCESSWIRE / August 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focused on the development of innovative ...
Yahoo Finance

Organicell Announces Matt Sinnreich as CEO

MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative ...
Nasdaq

Organicell Regenerative Medicine and Its Investigational Therapeutic Zofin™ Featured in Two National Publications Examining Potential Therapies for COVID-19 Long-Haulers

MIAMI BEACH, Fla.--(BUSINESS WIRE)-- Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) (the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of regenerative ...
The Globe and Mail

Organicell Regenerative Medicine, Inc. Responds to Recent Promotional Activities Pursuant to OTC Markets Request

DAVIE, FL / ACCESSWIRE / November 21, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) ("Organicell" or the "Company") has been requested by OTC Markets Group, Inc. ("OTC Markets") to issue ...
Business Wire

Organicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic Potential

MIAMI--(BUSINESS WIRE)--Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that ...
Nasdaq

Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19

MIAMI, May 05, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, ...
Business Wire

Organicell Announces FDA Approval of IND Application for the Use of Zofin™ in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

MIAMI--(BUSINESS WIRE)--Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that ...
The Globe and Mail

Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients

MIAMI, FL / ACCESSWIRE / February 8, 2022 /Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, ...
GEN

Organicell Regenerative Medicine – Zofin™ (Organcell™ Flow)

Type: Nanoparticle therapeutic derived from amniotic fluid and containing approximately 400 billion Extracellular Vesicles per milliliter. Extracellular Vesicles are nanovesicles that contain protein ...
Finanznachrichten

Organicell Regenerative Medicine, Inc. Announces Matt Sinnreich as CEO

MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative ...